2024/04/26 17:41:21 | |
---|---|
Price | |
100.50 EUR | |
Difference | 1.31% (1.30) |
ISIN | DE000A0LD6E6 |
Symbol | GXI |
Exchange | Xetra |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,471 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 99.80 EUR |
High | 101.70 EUR |
Low | 99.50 EUR |
Close (prev. day) | 99.20 EUR |
VWAP | 100.43523 EUR |
Volume (pcs) | 55,957 |
Trading volume | 5,620,053.90 |
Number of trades | 821 |
Last size | 100 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/04/26 | Global Equity Ratings | ||
2024/04/03 | Global Equity Ratings | ||
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings |
2024/04/26 17:41:21 | |
---|---|
Price | |
100.50 EUR | |
Difference | 1.31% (1.30) |
ISIN | DE000A0LD6E6 |
Symbol | GXI |
Exchange | Xetra |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 3,471 EUR |
Benchmark | GERMANY DAX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 99.80 EUR |
High | 101.70 EUR |
Low | 99.50 EUR |
Close (prev. day) | 99.20 EUR |
VWAP | 100.43523 EUR |
Volume (pcs) | 55,957 |
Trading volume | 5,620,053.90 |
Number of trades | 821 |
Last size | 100 |
6m | 1Y | 3Y | |
Perf (%) | +15.12% | +4.52% | +12.54% |
Perf (abs.) | +13.20 | +4.35 | +11.20 |
Beta | 1.11 | 0.94 | 0.87 |
Volatility | 40.54 | 39.13 | 36.63 |
Ø price 5 days | Ø volume 5 days (pcs.) | 100.88 EUR (77,991) |
Ø price 30 days | Ø volume 30 days (pcs.) | 103.04 EUR (103,700) |
Ø price 100 days | Ø volume 100 days (pcs.) | 97.12 EUR (110,027) |
Ø price 250 days | Ø volume 250 days (pcs.) | 100.78 EUR (112,736) |
YTD High | date | 111.20 EUR (2024/02/29) |
YTD Low | date | 84.80 EUR (2024/01/17) |
52 Weeks High | date | 122.90 EUR (2023/09/05) |
52 Weeks Low | date | 81.35 EUR (2023/11/16) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/04/26 | 17:41 | 100.50 EUR | 5.62 | 821 |
Vienna Stock Exchange | 2024/04/26 | 17:32 | 101.20 EUR | 0.00 | 2 |
Tradegate | 2024/04/26 | 22:26 | 100.50 EUR | 0.22 | 44 |
Stuttgart | 2024/04/26 | 21:30 | 100.00 EUR | 0.02 | 62 |
SIX Swiss Exchange | 2019/02/28 | 17:34 | 75.60 CHF | 0.00 | 1 |
Munich | 2024/04/26 | 08:02 | 100.30 EUR | 0.00 | 2 |
London Stock Exchange European Trade Reporting | 2024/04/26 | 17:30 | 101.40 EUR | 0.00 | 2 |
Hanover | 2024/04/26 | 08:16 | 99.85 EUR | 0.00 | 3 |
Hamburg | 2024/04/26 | 08:16 | 99.85 EUR | 0.00 | 3 |
Frankfurt | 2024/04/26 | 08:04 | 99.80 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/04/19 | 16:48 | 105.35 USD | 0.02 | 2 |
Duesseldorf | 2024/04/26 | 19:32 | 100.00 EUR | 0.00 | 6 |
Berlin | 2024/04/26 | 08:02 | 99.80 EUR | 0.00 | 2 |
GERRESHEIMER AG |
- - |
Klaus-Bungert-Strasse 4 - 40468 Düsseldorf |
Telefon: +49-211-6181-00 |
Fax: + |
E-mail: info@gerresheimer.com |
Gerresheimer AG engages in the manufacturing and supplies glass and plastic products for the pharmaceutical and healthcare industry. It operates through the following segments: Plastic and Devices, Primary Packaging Glass, and Advanced Technologies. The Plastic and Devices segment includes insulin pens, inhalers and refillable syringes as well as diagnostics and medical technology products such as skin-prick aids and test systems and pharmaceutical plastic containers for liquid and solid medicines. The Primary Packaging Glass segment refers to the primary packaging made of glass of medicines and cosmetics such as pharma jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, and special containers for food and drinks. The Advanced Technologies segment focuses on the technical and digital solutions to improve patient treatment outcomes. The company was founded in 1864 and is headquartered in Duesseldorf, Germany. |
Dietmar Siemssen | Chairman of Managing Board |
Bernd Metzner | Member of Executive Committee |
Lukas Burkhardt | Member of Executive Committee |
Axel Herberg | Chairman of Supervisory Board |
Annette Koehler | Member of Supervisory Board |
Karin Louise Dorrepaal | Member of Supervisory Board |
Peter Michael Noé | Member of Supervisory Board |
Andrea Abt | Member of Supervisory Board |
Francesco Grioli | Member of Supervisory Board |
Katja Mögel-Schnitzler | Member of Supervisory Board |
Markus Rocholz | Member of Supervisory Board |
Marlis Mergenthal | Member of Supervisory Board |
Paul Schilling | Member of Supervisory Board |
Robert Froehler | Member of Supervisory Board |
Udo Johannes Vetter | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer